Platform integrates health data from hundreds of health apps and wearables to enable preventive care and automated treatment.
Health data integration and analytics company Thryve has successfully raised €4 million in a Series A funding round to expand its international presence and accelerate the development of its health data infrastructure. The Berlin-based company’s core product is an API-based engine for healthcare organizations that integrates data from a wide array of consumer devices to enable preventative care and automated treatment.
As healthcare increasingly moves towards early detection and home-based treatment, Thryve aims to leverage the huge growth in wearables and health trackers to facilitate these advances. The company’s platform pulls data from hundreds of health trackers and sensors, allowing for continuous health assessments and supporting real-time preventive care.
Thryve currently supports health analytics across mental, cardiovascular, and metabolic health, with plans to broaden its scope to cover additional health markers while enabling customers to integrate their own algorithms into the company’s system. CEO Friedrich Lammel said that he believes the company’s technology can help add “20 healthy years to individual’s lives in the next five years.”
Designed to simplify data integration, Thryve manages over 100 different APIs in a single platform, including wearable devices such as the Apple Watch, Oura Ring, and specialized health sensors. The company claims its engine processes around one billion data points daily, and is compliant with key regulatory standards such as ISO27001 and ISO9001.
Thryve says its platform is widely adopted across Europe, with more than 50 million people already accessing its services through health insurers like Germany’s AOK and Spain’s Sanitas. The company’s platform was also used by the German government during the COVID-19 pandemic to monitor infection rates nationwide.
The recent funding round was led by Capricorn Partners of Belgium, with additional investments from IBB Ventures, CRB Health Tech of Spain, and Germany’s Carma Fund.
“This new investment aligns with our investment strategy to utilize real-world data for personalized prevention and therapeutics,” said Capricorn’s Antoine D´Hollander. “We are excited about Thryve’s solution to create a cost-efficient healthcare ecosystem by integrating data from numerous wearable devices and health apps, facilitating tailored interventions and effective monitoring.”
